A patient-focused, clinical decision-making algorithm to determine the optimal approach between single-port and multiport robotic surgery will help guide surgeons in selecting the appropriate treatment for each patient. This advance ushers in a new era of evidence-based, personalized surgical treatment for kidney cancer.